Esophagus Cancer Recruiting Phase 3 Trials for Mitometh (DB12117)

IndicationStatusPhase
DBCOND0032126 (Esophagus Cancer)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03002064Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC PatientsTreatment